Volume 21, 2017 Archive

Six issues from 2017 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2017 Vol. 21 No. 1	Volume 21, Number 1
March/April 2017 Vol. 21 No. 2	Volume 21, Number 2
May/June 2017 Vol. 21 No. 3	Volume 21, Number 3
July/August 2017 Vol. 21 No. 4	Volume 21, Number 4
September/October 2017 Vol. 21 No. 5	Volume 21, Number 5
November/December 2017 Vol. 21 No. 6	Volume 21, Number 6

Volume 21, 2017 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2017 Pg. 4	PreScription: Compounding Pharmacy Issues for 2017 Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017 Pg. 28	Why You Should Become an International Academy of Compounding Pharmacists Member Author(s): Gates Ernest P Jr
Jan/Feb 2017 Pg. 31-37	Analytic Methods Used in Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 47-56	Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Author(s): Akers Michael J
Jan/Feb 2017 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2017 Pg. 60	Clindamycin 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 61	Diazoxide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 63	Nifedipine 0.5% Rectal Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 65	Zonisamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 83-87	A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Author(s): Rush Steven D, Vernak Charlene, Zhao Fang
Mar/Apr 2017 Pg. 92	PreScription: Whatever Happened to Common Sense? Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Mar/Apr 2017 Pg. 105-108	Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Author(s): Benischek Rita
Mar/Apr 2017 Pg. 111-115	Consultation for Human, Veterinary, and Compounded Medications Author(s): Moghadam Gabriella, Forsythe Lauren Eichstadt
Mar/Apr 2017 Pg. 116-117	The International Academy of Compounding Pharmacists Introduces a New President Author(s): Rice Baylor
Mar/Apr 2017 Pg. 118-124	Quality Control: (Material) Safety Data Sheets Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 133-142	Accuracy Considerations in Sterile Compounding Author(s): Akers Michael J
Mar/Apr 2017 Pg. 144	Calculations Author(s): Stockton Shelly J
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 147	Candesartan Cilexetil 8 mg Liquid-Filled Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 148	Furosemide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 149	Ketoconazole 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 150-153	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Mar/Apr 2017 Pg. 154-159	Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Author(s): Gautam Pradeep, Light Bob, Purvis Troy
Mar/Apr 2017 Pg. 160-163	Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017 Pg. 171-175	Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
May/Jun 2017 Pg. 180	PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 182-190	Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding Author(s): Ligugnana Roberto
May/Jun 2017 Pg. 193-203	Microbiologic Testing for 503A Sterile-Compounding Pharmacies Author(s): Mixon William, Roth Abby
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017 Pg. 212-213	International Academy of Compounding Pharmacists Legislative/Regulatory Update Author(s): Rice Baylor
May/Jun 2017 Pg. 215-220	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
May/Jun 2017 Pg. 230-231	Calculations Author(s): Stockton Shelly J
May/Jun 2017 Pg. 232	Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 233	Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 235	Meloxicam 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 236	Ofloxacin 0.3% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 237	PVP Iodine 10% Antiseptic Cream Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 238	Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 239	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 240-241	Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2017 Pg. 247-250	Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance Author(s): Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero
May/Jun 2017 Pg. 251-254	Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes Author(s): McHenry Adam R, Wempe Michael F, Rice Peter J
May/Jun 2017 Pg. 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
Jul/Aug 2017 Pg. 268	PreScription: Just Think About It! Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 271-274	Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800> Author(s): Laniewicz Cheryl
Jul/Aug 2017 Pg. 277-280	Component Selection for Sterile Compounding Author(s): Dilzer Richard H
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Jul/Aug 2017 Pg. 290-291	The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Author(s): Rice Baylor
Jul/Aug 2017 Pg. 293-298	Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Jul/Aug 2017 Pg. 310	Calculations Author(s): Stockton Shelly J
Jul/Aug 2017 Pg. 312	Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 313	Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 314	Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 315	Disopyramide 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 316	Ferrous Sulfate 30-mg Fe/mL Oral Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 318	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 321	Tranilast 8% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017 Pg. 330-333	Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori Author(s): Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
Jul/Aug 2017 Pg. 334-338	Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Author(s): Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017 Pg. 339-346	Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 Author(s): de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Jul/Aug 2017 Pg. 347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Author(s): Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 358-362	Compounding Opportunities in Urology Author(s): Biundo Bruce
Sep/Oct 2017 Pg. 364-370	Child-safety Containers/Devices and Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J
Sep/Oct 2017 Pg. 382-383	IACP Legislative/Regulatory Update Author(s): International Academy of Compounding Pharmacists
Sep/Oct 2017 Pg. 384-387	Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting Author(s): Medi-Dose Inc./EPS Inc.
Sep/Oct 2017 Pg. 388-392	Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 395-404	Basics of Sterile Compounding: Particulate Matter Author(s): Akers Michael J
Sep/Oct 2017 Pg. 406	Calculations Author(s): Stockton Shelly J
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 409	Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 412	Fluoxymesterone 10-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 413	Ioversol Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 414	Levocarnitine 100-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 417	Vancomycin 50 mg/mL in Oral Syrup Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017 Pg. 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017 Pg. 430-435	Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt Author(s): Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Nov/Dec 2017 Pg. 444	PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Nov/Dec 2017 Pg. 454-461	Orodispersible Films for Compounding Pharmacies Author(s): Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017 Pg. 463-467	Features of Pharmaceutical Compounding in the Republic of Tajikistan Author(s): Alfred-Ugbenbo DS, Valiev AH, Zdoryk OA, Georgiyants VA
Nov/Dec 2017 Pg. 468	Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Author(s): Blankenship Cynthia
Nov/Dec 2017 Pg. 471-479	Basics of Compounding: Hot Melt Extrusion Author(s): DePasquale Seth
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 488	Calculations Author(s): Stockton Shelly J
Nov/Dec 2017 Pg. 490	Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 491	Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 492	Fluconazole 10% in RECURA Cream Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 493	Haloperidol 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 494	Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 495	Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 496	Spironolactone 5 mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 497	Tolmetin 400-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 498	Trace Elements Injection 5 Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 499	Vancomycin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017 Pg. 513-517	Validation of the Technological Process of the Preparation "Milk by Vidal" Author(s): Savchenko LP, Mishchenko VA, Georgiyants VA
Nov/Dec 2017 Pg. 518-529	Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland Author(s): Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob